Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

Peer Review reports

Original Submission
8 Nov 2019	Submitted	Original manuscript
19 Nov 2019	Author responded	Author comments - Phillip Good
Resubmission - Version 2
19 Nov 2019	Submitted	Manuscript version 2
Publishing
21 Nov 2019	Editorially accepted
6 Dec 2019	Article published	10.1186/s12904-019-0494-6

Back to article page